Hee-Seung Bom

Hee-Seung Bom

Auto-generated profile, based on publicly available information

Hee-Seung Bom

Department of Nuclear Medicine, Chonnam National University Hwasun Hospital, Hwasun-gun, Republic of Korea

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2012 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
JOJong-Ryool Oh
Jong-Ryool Oh
JSJi-Hyoung Seo
Ji-Hyoung Seo
ACAri Chong
Ari Chong
JMJung-Joon Min
Jung-Joon Min
HSHo-Chun Song
Ho-Chun Song
HBHee-Seung Bom
Hee-Seung Bom

23 May 2023 in Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Open access
PDF file
HBHee-Seung Henry Bom
Hee-Seung Henry Bom
The OpenAI tool "Chat Generative Pre-trained Tansformer (ChatGPT)," a popular artificial intelligence (AI) large language model (LLM), has recently gained attention for its potential applications and implications in various fields, including academic writing [1, 2]. Editors of Nuclear Medicine and Molecular Imaging (NMMI) are concerned about various issues that may arise from the use of ChatGPT in the research and publication process. To explore the potential benefits and problems of using ChatGPT in academic writing, a roundtable discussion was held on Saturday, April 22, 2023, from 9:15 to 9:45 a.m. at Conference Room 10 on the 5th floor of the Busan Port International Exhibition and Convention Center (BPEX) during the 2023 annual congress of the Korean Society of Nuclear Medicine (KSNM). I organized and moderated the meeting as the editor-in-chief of NMMI. The participants were invited from among the members of KSNM who have a deep interest in using LLM, including ChatGPT (Fig. 1). The list of participants, in alphabetical order by name, includes

5 September 2012 in Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
SYSu Woong Yoo
Su Woong Yoo
JKJahae Kim
Jahae Kim
ACAri Chong
Ari Chong
SKSeong-Young Kwon
Seong-Young Kwon
JMJung-Joon Min
Jung-Joon Min
HBHee-Seung Bom
Hee-Seung Bom

1 April 2006 in Annals of Nuclear Medicine
Verified
Journal Article
Closed access
PDF file
JMJung-Joon Min
Jung-Joon Min
SMSungmin Moon
Sungmin Moon
SKSung Mi Kim
Sung Mi Kim
HBHee-Seung Bom
Hee-Seung Bom
ULUyenchi N. Le
Uyenchi N. Le
KYKyung Yeon Yoo
Kyung Yeon Yoo

28 June 2014 in Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
HPHee Jeong Park
Hee Jeong Park
GJGeum-Cheol Jeong
Geum-Cheol Jeong
SKSeong Young Kwon
Seong Young Kwon
JMJung-Joon Min
Jung-Joon Min
HBHee-Seung Bom
Hee-Seung Bom
SYSu Woong Yoo
Su Woong Yoo

28 March 2015 in BMC Cancer
Verified
Journal Article
Open access
PDF file
SJSung-Hoon Jung
Sung-Hoon Jung
JAJae-Sook Ahn
Jae-Sook Ahn
YKYeo-Kyeoung Kim
Yeo-Kyeoung Kim
SKSun-Seog Kweon
Sun-Seog Kweon
YHYeongjin Hong
Yeongjin Hong
DYDeok-Hwan Yang
Deok-Hwan Yang
The role of interim PET/CT in peripheral T-cell lymphoma (PTCL) is less identified compared to other subtype of lymphoma. This study prospectively investigated the prognostic accuracy of sequential interim PET/CT using visual and quantitative assessment to determine whether it provided prognostic information for the treatment of PTCL. Sixty-three patients with newly diagnosed PTCL were enrolled, and 59 patients underwent interim PET/CT after three or four courses of induction treatment. The response of interim PET/CT was assessed by three parameters: the Deauville five-point scale (5-PS), ΔSUVmax, and ΔMTV2.5. Over a median follow up of 40.3 months, each assessment of interim PET/CT using the 5-PS, ΔSUVmax, and ΔMTV2.5 had predictive value for progression-free survival. To increase the predictive accuracy of interim PET/CT, we divided patients into three groups according to the sum of scores for three adverse responses based on the visual, SUV-based and MTV-based assessment: favorable, intermediate, and poor responder. The clinical outcome of patients in the favorable group was significantly superior to patients in the poor or intermediate group. Visual, quantitative SUV-based, and MTV-based assessment in interim PET/CT are valuable for early treatment response assessment in patients with PTCL, and the combined approach using the three parameters was more efficient in discriminating between patients with different survival outcomes compared with single-parameter assessment. NCT01470066 .